INTERLEUKINS-6 AND -11 EXPRESSION IN PRIMARY BREAST CANCER AND SUBSEQUENT DEVELOPMENT OF BONE METASTASES.A LOW-DENSITY DNA MICROARRAY FOR ANALYSIS OF MARKERS IN BREAST CANCER.
Main menu


Marc Lacroix - List of publications - Click here

ESTROGEN RECEPTOR ANALYSIS IN PRIMARY BREAST TUMORS BY LIGAND-BINDING ASSAY, IMMUNOCYTOCHEMICAL ASSAY, AND NORTHERN BLOT: A COMPARISON.


Marc Lacroix, Gilbert Querton, Philippe Hennebert, Denis Larsimont, Guy Leclercq
Breast Cancer Research and Treatment (2001) 67, 263-271

   Estrogen receptor (ER) status is an important parameter in breast cancer management. In this study, ER protein contents established by two conventional techniques were confronted to ER mRNA level, to analyze whether the latter may be introduced in routine assay. Eighty-seven breast tumor samples were examined. ER amounts were determined by ligand-binding assay (LBA) and by computer-assisted immunocytochemical assay (ICA). For ER mRNA analysis and quantification, northern blot was used; MCF-7 and MDA-MB-231 breast cancer cell lines served as positive and negative controls, respectively. Seventy-seven percent of tumor samples examined were positive for ER mRNA and they all expressed the 6.7-kb receptor signal. No trace of small-sized ER mRNA variants was detected in any sample. Following Akaike Information Criterion (AIC) discriminant analysis, a simple linear correlation was found between ER mRNA levels and ER amounts provided by LBA. This was not observed when either mRNA or LBA values were compared to ICA values. These latter were found to rapidly reach a plateau at increasing mRNA or LBA values. In conclusion, our data points to the linear correlation between ER amounts determined in breast tumors at both protein and mRNA levels by quantitative methods; they also indicate that the semi-quantitative computer-associated ICA may complement rather than replace these quantitative methods.


To obtain a copy (PDF file) of this paper, please CLICK HERE or contact the Webmaster.



Main Menu



Webmaster / Webmestre: Marc Lacroix
This page hosted by/Page hébergée par
Get your own Free Home Page /Obtenez votre page personnelle gratuite

Made in BELGIUM / WALLONIA / EUREGIO MAAS-RHINE - Fait en BELGIQUE / WALLONIE / EUREGIO MEUSE-RHIN - (Molecular breast cancer - Cancer du sein, aspects moléculaires) - Marc Lacroix & SciMedWeb® 2001-2009